Friday, October 9, 2009
Buffalo, NY - Roswell Park Cancer Institute (RPCI) has received a $2.1M National Institutes of Health grant to assess smokers' interest in smokeless tobacco products. Richard O'Connor, PhD, of the Health Behavior Department at RPCI, is the principal investigator.
Read more
Friday, October 9, 2009
BUFFALO, NY - Roswell Park Cancer Institute (RPCI) has licensed its photodynamic therapy (PDT) technology to pharmaceutical companies in India and China, reports Richard Matner, PhD, MBA, Director of RPCI's Technology Transfer Office.
Read more
Thursday, October 8, 2009
Event focuses on family members, teachers, and school personnel
Read more
Tuesday, October 6, 2009
BUFFALO, NY – Roswell Park Cancer Institute (RPCI) will host the third annual Dr. Enrico Mihich lecture series on Wednesday, October 14, at 8 am in the Zebro Conference Room, Center for Genetics and Pharmacology, on the main RPCI campus. “Mechanisms and Therapeutic Targeting of the...
Read more
Tuesday, October 6, 2009
BUFFALO, NY - Roswell Park Cancer Institute (RPCI) and the University at Buffalo (UB) have received a $400,000 grant from the U.S. Department of Education to establish a dual master's degree program in the biology and systems of cancer. The RPCI/UB team will work collaboratively with universities...
Read more
Monday, October 5, 2009
BUFFALO, NY - Roswell Park Cancer Institute (RPCI) will host a workshop on translational research on Tuesday, November 3, from 8am to 4:30pm in the Zebro Conference Room, Center for Genetics and Pharmacology, on the main RPCI campus.
Read more
Monday, October 5, 2009
Buffalo, NY - Roswell Park Cancer Institute (RPCI) has been awarded a $1.8 million National Institutes of Health (NIH) grant to study new therapeutic approaches for treating B-cell non-Hodgkin's lymphoma (B-NHL). Myron Czuczman, MD, Chief Lymphoma/Myeloma Section of the Department of Medicine at...
Read more
Thursday, October 1, 2009
Buffalo, NY - Roswell Park Cancer Institute (RPCI) appointed John Kasznica, MD to the department of Pathology. Dr. Kasznica comes to RPCI from Women and Infants Hospital (WIHRI) in Providence, RI, where he was part of the obstetric/newborn service line evaluation committee serving as a staff...
Read more
Thursday, October 1, 2009
BUFFALO, NY - Breast cancer therapy that's customized for each patient's personal genetic makeup is one step closer to reality, thanks to a new use for crime-lab technology pioneered at Roswell Park Cancer Institute (RPCI). A team led by Petr Starostik, MD, chief of RPCI's Clinical...
Read more
Monday, September 28, 2009
An increasing number of women diagnosed with cancer in one breast are opting to have their healthy breast surgically removed, according to a recent study of New York State data. The study also finds that, despite extensive press coverage of women who choose to have both breasts removed because of a...
Read more
